Our previous studies showed that up-regulation of fibroblast growth factor (FGF)15/19 signaling and its receptors FGFR4/beta-klotho in NASH-HCC mice and in HCC patients 6, 7. Here, KLB is linked to metabolic dysfunction-associated steatohepatitis.